8-K: Agape ATP Faces Nasdaq Delisting Risk Over Bid Price

Agape ATP Corporation received a Nasdaq notice for failing to meet the minimum $1 bid price requirement, initiating a 180-day compliance period.

Summary

• Agape ATP Corporation (ATPC) received a notification from Nasdaq on January 27, 2026, regarding non-compliance with the minimum bid price requirement.
• The company's common stock closing bid price fell below $1.00 per share for the period from December 10, 2025, to January 26, 2026, violating Nasdaq Listing Rule 5550(a)(2).
• ATPC has been granted an initial 180-calendar-day compliance period, until July 27, 2026, to regain compliance.
• Failure to regain compliance within this period may lead to eligibility for an additional 180-day period, provided the company meets other listing standards and intends to cure the deficiency, potentially through a reverse stock split.
• If compliance is not achieved, Nasdaq will issue a delisting notice for the company's securities.
• The company is evaluating options and intends to regain compliance, though there is no assurance it will succeed.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the formal non-compliance notice and the inherent risk of delisting, despite the provided compliance period. The lack of assurance regarding regaining compliance adds to the negative sentiment.

Positives

• The notice does not result in immediate delisting, and the common stock will continue to trade on Nasdaq under the symbol ATPC.
• The company has a clear 180-day period to regain compliance, with a potential for an additional 180 days.

Negatives

• Agape ATP Corporation is not in compliance with Nasdaq Listing Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share.
• The company's stock price has been below $1.00 for a sustained period from December 10, 2025, to January 26, 2026.
• There is no assurance that the company will be able to regain compliance within the specified timeframes.
• Failure to regain compliance could lead to the delisting of the company's securities from the Nasdaq Capital Market.

Risks

• Potential delisting of ATPC's common stock from the Nasdaq Capital Market if the company fails to regain compliance with the minimum bid price requirement.
• Uncertainty regarding the company's ability to implement effective strategies, such as a reverse stock split, to cure the deficiency.
• Risk that the company may not meet other Nasdaq continued listing requirements, even if the bid price issue is addressed.

Future Outlook

The company is currently evaluating options to regain compliance with Nasdaq's continued listing requirements and intends to timely regain compliance. However, there is no assurance that it will be able to do so within the applicable time periods.

Management Comments

• "The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaqs continued listing requirement."
• "Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement."

Industry Context

StockSavvy.ai notes that companies often face delisting risks when their stock price consistently trades below the minimum bid price, a common challenge for smaller or emerging growth companies on major exchanges like Nasdaq. This situation can impact investor confidence and liquidity, potentially limiting access to capital markets.

Stakeholder Impact

• Shareholders: Face increased risk of delisting, which could lead to reduced liquidity, lower stock price, and potential transfer to over-the-counter markets, impacting investment value.
• Investors: May view the company as higher risk due to compliance issues, potentially affecting future investment decisions.

Next Steps

• Agape ATP Corporation will evaluate options to regain compliance with Nasdaq's minimum bid price requirement.
• The company must regain a closing bid price of $1.00 or more for at least 10 consecutive business days by July 27, 2026.
• If compliance is not regained by July 27, 2026, the company may be eligible for an additional 180-day compliance period if it meets other listing standards and provides written notice of intent to cure, potentially through a reverse stock split.
• If compliance is not achieved within the extended period, Nasdaq will provide notice that the company's securities will be subject to delisting.

Key Dates

Recommendation

The notification of non-compliance with Nasdaq's minimum bid price requirement introduces significant uncertainty and risk of delisting. While a compliance period is granted, the company offers no assurance of regaining compliance. Delisting would severely impact liquidity and investor confidence, making the stock a high-risk proposition. A seasoned investor would likely consider selling to avoid potential further downside and loss of exchange listing.

Keywords

Agape ATP Corporation, ATPC, Nasdaq, delisting, minimum bid price, compliance, stock market, reverse stock split, health and wellness, energy-saving solutions